{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:23Z","timestamp":1791357263953,"version":"4.3.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.lpm.2018.10.003","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T23:33:23Z","timestamp":1540510403000},"page":"886-891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Usages et m\u00e9susages des benzodiaz\u00e9pines chez les patients souffrant de troubles psychiatriques"],"prefix":"10.1016","volume":"47","author":[{"given":"Arnaud","family":"Panes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Fourrier-R\u00e9glat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Verdoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2018.10.003_bib0155","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/pds.4123","article-title":"Trends in incident use of benzodiazepines and Z-drugs in France from 2006\u00a0to 2012: a population-based study","volume":"26","author":"B\u00e9nard-Laribi\u00e8re","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.lpm.2018.10.003_bib0160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2125.2012.04418.x","article-title":"Benzodiazepine harm: how can it be reduced?","volume":"77","author":"Lader","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.lpm.2018.10.003_bib0165","series-title":"Am\u00e9lioration de la prescription chez le sujet \u00e2g\u00e9\u00a0: les indicateurs d\u2019alerte et de ma\u00eetrise de la iatrog\u00e9nie. Benzodiaz\u00e9pine \u00e0 demi vie longue chez le sujet \u00e2g\u00e9","author":"Haute Autorit\u00e9 de sant\u00e9 (HAS)","year":"2011"},{"key":"10.1016\/j.lpm.2018.10.003_bib0170","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.genhosppsych.2015.06.004","article-title":"Demographic and clinical factors associated with benzodiazepine prescription at discharge from psychiatric inpatient treatment","volume":"37","author":"Peters","year":"2015","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.003_bib0175","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11096-007-9096-0","article-title":"Sedative-hypnotic treatment in an acute psychiatric setting: comparison with best practice guidance","volume":"29","author":"Wheeler","year":"2007","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.lpm.2018.10.003_bib0180","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4088\/JCP.09m05019yel","article-title":"Benzodiazepine use and risk of recurrence in bipolar disorder","volume":"71","author":"Perlis","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.003_bib0185","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.euroneuro.2015.03.017","article-title":"Psychopharmacological treatment of 2195\u00a0in-patients with borderline personality disorder: a comparison with other psychiatric disorders","volume":"25","author":"Bridler","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.lpm.2018.10.003_bib0190","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/fcp.12167","article-title":"Compliance of psychotropic drug prescription with clinical practice guidelines in older inpatients","volume":"30","author":"Etchepare","year":"2016","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.lpm.2018.10.003_bib0195","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jad.2014.11.058","article-title":"Gender differences in the treatment of patients with bipolar disorder: a study of 7354\u00a0patients","volume":"174","author":"Karanti","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1016\/j.lpm.2018.10.003_bib0200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jad.2015.11.037","article-title":"Psychopharmacological treatment of 1650\u00a0in-patients with acute mania-data from the AMSP study","volume":"191","author":"Kleimann","year":"2016","journal-title":"J Affect Disord"},{"key":"10.1016\/j.lpm.2018.10.003_bib0205","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1176\/appi.ps.54.10.1395","article-title":"Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders","volume":"54","author":"Brunette","year":"2003","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.lpm.2018.10.003_bib0210","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4088\/JCP.v65n0202","article-title":"Benzodiazepine prescription practices and substance abuse in persons with severe mental illness","volume":"65","author":"Clark","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.003_bib0215","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1176\/appi.ajp.161.4.654","article-title":"Benzodiazepine use among depressed patients treated in mental health settings","volume":"161","author":"Valenstein","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.003_bib0220","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1176\/appi.ajp.160.8.1432","article-title":"Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?","volume":"160","author":"Bruce","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.003_bib0225","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1176\/ps.62.8.pss6208_0908","article-title":"Benzodiazepine use among patients with schizophrenia in taiwan: a nationwide population-based survey","volume":"62","author":"Wu","year":"2011","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.lpm.2018.10.003_bib0230","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.janxdis.2012.11.004","article-title":"National trends of psychotropic medication use among patients diagnosed with anxiety disorders: results from Medical Expenditure Panel Survey 2004\u20132009","volume":"27","author":"Wu","year":"2013","journal-title":"J Anxiety Disord"},{"key":"10.1016\/j.lpm.2018.10.003_bib0235","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jad.2015.09.013","article-title":"Major depression treatment in Germany\u2013descriptive analysis of health insurance fund routine data and assessment of guideline-adherence","volume":"189","author":"Wiegand","year":"2016","journal-title":"J Affect Disord"},{"key":"10.1016\/j.lpm.2018.10.003_bib0240","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.psychres.2017.09.059","article-title":"Prescribing practices in Southeastern Europe - focus on benzodiazepine prescription at discharge from nine university psychiatric hospitals","volume":"258","author":"Maric","year":"2017","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.lpm.2018.10.003_bib0245","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4088\/JCP.15m10271","article-title":"Benzodiazepine use and risk of mortality among patients with schizophrenia","volume":"77","author":"Fontanella","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.003_bib0250","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamapsychiatry.2017.1273","article-title":"Simultaneous antidepressant and benzodiazepine new use and subsequent long-term benzodiazepine use in adults with depression, United States, 2001\u20132014","volume":"74","author":"Bushnell","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.003_bib0255","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archgenpsychiatry.2011.1532","article-title":"Polypharmacy with antipsychotics, antidepressants or benzodiazepines and mortality in schizophrenia","volume":"69","author":"Tiihonen","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.003_bib0260","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00213-015-4167-8","article-title":"Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset","volume":"233","author":"Fond","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.lpm.2018.10.003_bib0265","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/appi.ajp.2015.15050618","article-title":"Mortality and cumulative exposure to antipsychotics, antidepressants, and benzodiazepines in patients with schizophrenia: an observational follow-up study","volume":"173","author":"Tiihonen","year":"2016","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.003_bib0270","first-page":"CD006391","article-title":"Benzodiazepines for schizophrenia","volume":"11","author":"Dold","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2018.10.003_bib0275","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/10401230802177698","article-title":"Does acute treatment with sedatives\/hypnotics for anxiety in depressed patients affect suicide risk? A literature review","volume":"20","author":"Youssef","year":"2008","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.003_bib0280","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/JCP.0000000000000257","article-title":"Complexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: results from the Bipolar CHOICE study","volume":"35","author":"Bobo","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.lpm.2018.10.003_bib0285","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4088\/JCP.08m04818yel","article-title":"Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia","volume":"71","author":"Baandrup","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.003_bib0290","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/NMD.0000000000000348","article-title":"Determinants of treatment-resistant depression: the salience of benzodiazepines","volume":"203","author":"Parker","year":"2015","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.lpm.2018.10.003_bib0295","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1192\/bjp.165.1.79","article-title":"Safety and side-effects of alprazolam. Controlled study in agoraphobia with panic disorder","volume":"165","author":"O'Sullivan","year":"1994","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.lpm.2018.10.003_bib0150","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00213-013-3127-4","article-title":"Benzodiazepine therapy in psychiatric outpatients is associated with deliberate self-poisoning events at emergency departments\u2014a population-based nested case\u2013control study","volume":"229","author":"Shih","year":"2013","journal-title":"Psychopharmacology (Berl)"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498218303816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498218303816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T21:09:34Z","timestamp":1543439374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498218303816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0755498218303816"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2018.10.003","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usages et m\u00e9susages des benzodiaz\u00e9pines chez les patients souffrant de troubles psychiatriques","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2018.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}